Ethyl-EPA in Alzheimer's disease - A pilot study

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 5, 2004, Pages 341-346

  Boston, Paul F ^a   Bennett, Amanda ^a   Horrobin, David F ^b   Bennett, Crispin N ^b  

^a Nether Edge Hospital   (United Kingdom)

^b Laxdale Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; ICOSAPENTAENOIC ACID ETHYL ESTER;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDEMA; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; LINEAR SYSTEM; MALE; PRIORITY JOURNAL; RASH; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FEMALE; HUMANS; MALE; PILOT PROJECTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4544364190     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.07.001     Document Type: Article

References (15)

1. M. Sano, C. Ernesto, and M.R. Klauber Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study Alzheimer Dis. Assoc. Disord. 10 1996 132 140
2. L.J. McIntosh, M.A. Trush, and J.C. Troncoso Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes Free Rad. Biol. Med. 23 1997 183 190
3. A.A. Farooqui, M.L. Litsky, T. Farooqui, and L.A. Horrocks Inhibitors of intracellular phospholipase A2 activity their neurochemical effects and therapeutical importance for neurological disorders Brain Res. Bull. 49 1999 139 153
4. D. Stephenson, K. Rash, and B. Smalstig Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration Glia 27 1999 110 128
5. F.M. Corrigan, D.F. Horrobin, E.R. Skinner, J.A. Besson, and M.B. Cooper Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl coA content Int. J. Biochem. Cell Biol. 30 1998 197 207
6. F.M. Corrigan, A. Van Rhijn, and D.F. Horrobin Essential fatty acids in Alzheimer's disease Ann. NY Acad. Sci. 640 1991 250 252
7. E.R. Skinner, C. Watt, J.A. Besson, and P.V. Best Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects Brain 116 1993 717 725
8. M. Soderberg, C. Edlund, K. Kristensson, and G. Dallner Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease Lipids 26 1991 421 425
9. B.K. Puri, G.M. Bydder, and S.J. Counsell MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment Neuroreport 13 2002 123 126
10. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state a practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
11. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am. J. Psychiatry 141 1984 1356 1364
12. M. Holland, How fatty acids can prevent weight loss, Health and Ageing (2002) 27-30.
13. G.P. Wolf-Klein, and F.A. Silverstone Weight loss in Alzheimer's disease an international review of the literature Int. Psychogeriatr. 6 1994 135 142
14. J. Powell-Tuck, K.D. MacRae, M.J.R. Healy, J.E. Lennard-Jones, and R.A. Parkins A defence of the small clinical trial evaluation of three gastroenterological studies Br. Med. J. 292 1986 599 602
15. M.L. Selley, D.R. Close, and S.E. Stern The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease Neurobiol. Aging 23 2002 383 388